Antibiotic Treatment for Lower Respiratory Tract Infections

Introduction to Antibiotic Selection

• The European Respiratory Society recommends amoxicillin or tetracycline as first-line antibiotics for outpatient lower respiratory tract infections (LRTIs) with a suspected bacterial cause, with macrolides or fluoroquinolones reserved for penicillin allergy or high local resistance rates 1, 2

When to Prescribe Antibiotics

• Antibiotics should only be prescribed when there is suspected or confirmed pneumonia, COPD exacerbations with all three cardinal symptoms, or in high-risk patients such as those over 75 years with fever, cardiac failure, insulin-dependent diabetes, or serious neurological disorder 1, 2

Outpatient Antibiotic Selection Algorithm

• For previously healthy adults without comorbidities, amoxicillin is the preferred first-line treatment, with tetracycline as an alternative first-line option 1, 2, 3
• The treatment duration for uncomplicated LRTI or bronchitis is 5-7 days 3, 1, 4

Community-Acquired Pneumonia (CAP)

• For healthy adults with CAP, amoxicillin 1g three times daily is the most effective treatment against S. pneumoniae, the most common pathogen 4
• For adults with comorbidities, combination therapy with a beta-lactam plus a macrolide, or monotherapy with a respiratory fluoroquinolone, is recommended 4

Special Situations

• For suspected aspiration pneumonia or pulmonary abscess, amoxicillin-clavulanate 2g IV every 6 hours is recommended, with clindamycin 600mg IV every 8 hours as an alternative 5, 4
• For suspected Legionella pneumophila, extended duration of 21 days of treatment with a macrolide plus rifampicin is recommended 5, 6, 4

Monitoring Response

• Patients should expect clinical improvement within 3 days of starting antibiotics and should return if fever persists for more than 4 days or if there is no improvement by 3 days 1, 2
• For hospitalized patients, response should be assessed at day 2-3 and alternative diagnoses or complications should be considered if there is no improvement 5, 4

Critical Pitfalls to Avoid

• Antibiotics should not be prescribed for viral bronchitis in otherwise healthy adults, as most LRTIs are self-limiting 1, 2
• Local resistance patterns should be considered when selecting antibiotics, and macrolides should only be used where pneumococcal resistance is less than 25% 1, 2, 4
• Fluoroquinolones should be avoided as first-line treatment due to adverse effect profile and resistance concerns 4